BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 32905204)

  • 21. Ductal carcinoma in situ of the breast--current management.
    Sharma S; Hill AD; McDermott EW; O'Higgins NJ
    Eur J Surg Oncol; 1997 Jun; 23(3):191-7. PubMed ID: 9236888
    [TBL] [Abstract][Full Text] [Related]  

  • 22. No survival advantage for mastectomy vs breast conservation therapy.
    Oncology (Williston Park); 2011 Oct; 25(11):1095. PubMed ID: 22106565
    [No Abstract]   [Full Text] [Related]  

  • 23. Breast conservation therapy versus mastectomy in the community-based setting: can this rate be used as a benchmark for cancer care?
    Nelson MC; Norton HJ; Greene FL
    Surg Oncol Clin N Am; 2011 Jul; 20(3):427-37, vii. PubMed ID: 21640912
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Proceedings of the Consensus Conference on Breast Conservation, April 28 to May 1, 2005, Milan, Italy.
    Schwartz GF; Veronesi U; Clough KB; Dixon JM; Fentiman IS; Heywang-Köbrunner SH; Holland R; Hughes KS; Margolese R; Olivotto IA; Palazzo JP; Solin LJ;
    Cancer; 2006 Jul; 107(2):242-50. PubMed ID: 16770785
    [No Abstract]   [Full Text] [Related]  

  • 25. Psychological outcomes of different treatment policies in women with early breast cancer outside a clinical trial.
    Fallowfield LJ; Hall A; Maguire GP; Baum M
    BMJ; 1990 Sep; 301(6752):575-80. PubMed ID: 2242455
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Breast conservation following neoadjuvant therapy for breast cancer.
    Catanuto G; Rocco N; Nava MB
    Minerva Chir; 2018 Jun; 73(3):297-299. PubMed ID: 29589678
    [No Abstract]   [Full Text] [Related]  

  • 27. Variability in reexcision following breast conservation surgery.
    McCahill LE; Single RM; Aiello Bowles EJ; Feigelson HS; James TA; Barney T; Engel JM; Onitilo AA
    JAMA; 2012 Feb; 307(5):467-75. PubMed ID: 22298678
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Partial mastectomy vs. breast ablation in treatment of invasive lobulary carcinoma].
    Julínek S; Winkler L; Seckarová D
    Rozhl Chir; 2007 Mar; 86(3):131-3. PubMed ID: 17591420
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Greater Well-being After Breast Conservation Surgery vs Mastectomy.
    Slomski A
    JAMA; 2022 Jun; 327(21):2066. PubMed ID: 35670799
    [No Abstract]   [Full Text] [Related]  

  • 30. Evaluation of eligibility and utilization of breast conservation treatment in an Asian context.
    Tan MP; Sitoh NY; Sim AS
    Asian Pac J Cancer Prev; 2014; 15(11):4683-8. PubMed ID: 24969904
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Controversies in breast conservation treatment for breast cancer].
    Motomura K; Egawa C; Komoike Y; Inaji H; Koyama H
    Gan To Kagaku Ryoho; 2004 Feb; 31(2):168-75. PubMed ID: 14997746
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Quality assessment of neoadjuvant therapy use in breast conservation: barriers to implementation.
    James T; McCahill L; Ratliff J; Ashikaga T; Single R; Sheehey-Jones J; Messier N; Stanley M; Krag D; Harlow S
    Breast J; 2009; 15(5):524-6. PubMed ID: 19624412
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The Importance of Breast Conservation Therapy in Young Women: Breast Conservation in the Young.
    Barry P
    JAMA Surg; 2017 Dec; 152(12):1182. PubMed ID: 28768304
    [No Abstract]   [Full Text] [Related]  

  • 34. Breast conservation in the setting of contemporary multimodality treatment provides excellent outcomes for patients with occult primary breast cancer.
    Rueth NM; Black DM; Limmer AR; Gabriel E; Huo L; Fornage BD; Dogan BE; Chavez-MacGregor M; Yi M; Hunt KK; Strom EA
    Ann Surg Oncol; 2015 Jan; 22(1):90-5. PubMed ID: 25249256
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The influence of gender of the surgeon on surgical procedure preference for breast cancer.
    Weinberg E; Woods S; Grannan K; Hendy MP
    Am Surg; 2002 Apr; 68(4):398-400. PubMed ID: 11952257
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Problems with the use of breast conservation therapy for breast cancer in a patient with neurofibromatosis type 1: a case report.
    Hasson DM; Khera SY; Meade TL; Dupont EL; Greenberg HM; Diaz NM; Romilly AP; Cox CE
    Breast J; 2008; 14(2):188-92. PubMed ID: 18248558
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Ductal carcinoma in situ (DCIS) of the breast: evolving perspectives.
    Sakorafas GH; Tsiotou AG
    Cancer Treat Rev; 2000 Apr; 26(2):103-25. PubMed ID: 10772968
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Oncoplastic breast conservation occupies a niche between standard breast conservation and mastectomy - A population-based prospective audit in Scotland.
    Morrow ES; Stallard S; Doughty J; Malyon A; Barber M; Dixon JM; Romics L
    Eur J Surg Oncol; 2019 Oct; 45(10):1806-1811. PubMed ID: 30902354
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Surgical treatment for invasive lobular carcinoma of the breast.
    Hussien M; Lioe TF; Finnegan J; Spence RA
    Breast; 2003 Feb; 12(1):23-35. PubMed ID: 14659352
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Mastectomy or breast conservation in the management of primary breast cancer: psychosocial factors.
    Wolberg WH
    Oncology (Williston Park); 1990 Oct; 4(10):101-4; discussion 104, 106, 108. PubMed ID: 2149819
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.